Skirball Institute of Biomolecular Medicine, Department of Cell Biology, NYU School of Medicine, New York, NY 10016, USA.
Institute for Systems Genetics and Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY 10016, USA.
Mol Cell. 2021 Jun 3;81(11):2349-2360.e6. doi: 10.1016/j.molcel.2021.03.033. Epub 2021 Apr 13.
Telomere length control is critical for cellular lifespan and tumor suppression. Telomerase is transiently activated in the inner cell mass of the developing blastocyst to reset telomere reserves. Its silencing upon differentiation leads to gradual telomere shortening in somatic cells. Here, we report that transcriptional regulation through cis-regulatory elements only partially accounts for telomerase activation in pluripotent cells. Instead, developmental control of telomerase is primarily driven by an alternative splicing event, centered around hTERT exon 2. Skipping of exon 2 triggers hTERT mRNA decay in differentiated cells, and conversely, its retention promotes telomerase accumulation in pluripotent cells. We identify SON as a regulator of exon 2 alternative splicing and report a patient carrying a SON mutation and suffering from insufficient telomerase and short telomeres. In summary, our study highlights a critical role for hTERT alternative splicing in the developmental regulation of telomerase and implicates defective splicing in telomere biology disorders.
端粒长度的控制对细胞寿命和肿瘤抑制至关重要。端粒酶在发育中的囊胚内细胞团中短暂激活,以重置端粒储备。在分化过程中端粒酶的沉默导致体细胞中端粒逐渐缩短。在这里,我们报告说,通过顺式调控元件的转录调控仅部分解释了多能细胞中端粒酶的激活。相反,端粒酶的发育控制主要由一个围绕 hTERT 外显子 2 的剪接事件驱动。外显子 2 的跳过触发分化细胞中 hTERT mRNA 的降解,相反,其保留促进了多能细胞中端粒酶的积累。我们确定 SON 是外显子 2 剪接的调节剂,并报告了一名携带 SON 突变并患有端粒酶不足和端粒短的患者。总之,我们的研究强调了 hTERT 剪接在端粒酶发育调控中的关键作用,并暗示剪接缺陷与端粒生物学紊乱有关。